AGBL3 and rheumatoid arthritis: Therefore, anti-CCP3.1 levels below 60 AU/ml did not appear to be meaningful or could even be misleading because the majority of patients with low antibody levels (33 out of 38) did not have a diagnosis of RA (Table 2).